Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells-Reference-Cited by-同舟云学术

Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells

Published:2021-07-27 Issue:9 Volume:112 Page:3895-3910
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Wang Zaozao¹^ORCID,Kang Bin²,Gao Qianqian²,Huang Lei²,Di Jiabo¹,Fan Yingcong¹,Yu Jianhong¹,Jiang Beihai¹,Gao Feng²,Wang Dan²,Sun Haixi²,Gu Ying²,Li Jian³,Su Xiangqian¹

Affiliation:

1. Department of Gastrointestinal Surgery IV Key Laboratory of Carcinogenesis and Translational Research Peking University Cancer Hospital and Institute Beijing China

2. BGI‐Shenzhen Shenzhen China

3. Department of Gastrointestinal Oncology Key Laboratory of Carcinogenesis and Translational Research Peking University Cancer Hospital and Institute Beijing China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15049

Reference52 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Molecular Basis of Colorectal Cancer

3. Targeting the untargetable KRAS in cancer therapy

4. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

5. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics;Expert Review of Molecular Diagnostics;2024-08-02

2. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer;Cell Death & Disease;2024-07-03

3. Identification of adipokine-related gene-based molecular subtypes of colon cancer and prognostic characteristics;Colorectal Cancer;2024-06-21

4. A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer;Nano Today;2024-06

5. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09